Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice

Thyroid

Volumn 23, Issue 12, 2013, Pages 1590-1599

  Kari, Suresh ^a,e   Flynn, Jeffrey C ^b   Zulfiqar, Muhammad ^c   Snower, Daniel P ^c   Elliott, Bruce E ^d   Kong, Yi Chi M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PROVIDENCE HOSPITAL   (United States)

^c ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^d QUEEN S UNIVERSITY   (Canada)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; INTERLEUKIN 1; OKT 4; OKT 8; THYROGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VOLUME;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FEMALE; HASHIMOTO DISEASE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED CBA; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 84890350664     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0064     Document Type: Article

References (26)

1. Kong YM, Wei W-Z, Tomer Y 2010 Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation. Ann NY Acad Sci 1183: 222-236.
2. Amos SM, Duong CP, Westwood JA, Ritchie DS, Junghans RP, Darcy PK, Kershaw MH 2011 Autoimmunity associated with immunotherapy of cancer. Blood 118: 499-509.
3. Downey SG, Klapper JA, Smith FO, Yang JC, Sherry RM, Royal RE, Kammula US, Hughes MS, Allen TE, Levy CL, Yellin M, Nichol G, White DE, Steinberg SM, Rosenberg SA 2007 Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade. Clin Cancer Res 13: 6681-6688. (Pubitemid 350206804)
4. Ribas A, Hanson DC, Noe DA, Millham R, Guyot DJ, Bernstein SH, Canniff PC, Sharma A, Gomez-Navarro J 2007 Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer. Oncologist 12: 873-883. (Pubitemid 47328230)
5. Jacobson DL, Gange SJ, Rose NR, Graham NMH 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84: 223-243. (Pubitemid 27398022)
6. Okayasu I, Hatakeyama S, Tanaka Y, Sakurai T, Hoshi K, Lewis PD 1991 Is focal chronic autoimmune thyroiditis an age-related disease? Differences in incidence and severity between Japanese and British. J Pathol 163: 257-264.
7. Okayasu I, Hara Y, Nakamura K, Rose NR 1994 Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am J Clin Pathol 101: 698-702. (Pubitemid 24169300)
8. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87: 489-499. (Pubitemid 34158210)
9. McNeelDG, KnutsonKL, SchiffmanK,DavisDR,CaronD,Disis ML 2003 Pilot study on an HLA-A2 peptide vaccine using Flt3 ligand as a systemic vaccine adjuvant. J Clin Immunol 23: 62-72. (Pubitemid 36207978)
10. ElRehewy M, Kong YM, Giraldo AA, Rose NR 1981 Syngeneic thyroglobulin is immunogenic in good responder mice. Eur J Immunol 11: 146-151. (Pubitemid 11143417)
11. Morris GP, Brown NK, Kong YM 2009 Naturally-existing CD4+CD25+Foxp3+ regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun 33: 68-76.
12. Morris GP, Yan Y, David CS, Kong YM 2005 H2A- and H2Ederived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis. J Immunol 174: 3111-3116. (Pubitemid 40279734)
13. Wei W-Z, Jacob JB, Zielinski JF, Flynn JC, Shim KD, Alsharabi G, Giraldo AA, Kong YM 2005 Concurrent induction of antitumor immunity and autoimmune thyroiditis inCD4+CD25+ regulatory T cell-depleted mice. Cancer Res 65: 8471-8478. (Pubitemid 41330615)
14. Jacob JB, Kong YM, Nalbantoglu I, Snower DP,Wei W-Z 2009 Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. J Immunol 182: 5873-5881.
15. Kong YM, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hämmerling GJ, David CS 1996 HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 184: 1167-1172.
16. Jacob JB, Kong YM, Meroueh C, Snower DP, David CS, Ho Y-S, Wei W-Z 2007 Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells. Cancer Res 67: 7020-7027. (Pubitemid 47105551)
17. Flynn JC, Wan Q, Panos JC, McCormick DJ, Giraldo AA, David CS, Kong YM 2002 Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3- mediated thyroiditis. J Autoimmun 18: 213-220. (Pubitemid 36269070)
18. Elliott BE, Xu W, Brissette L, Deeley RG, Mudrik K, Marshall J, Vekemans M, Holden JJA 1991 Outgrowth of stable class I major histocompatibility complex-expressing subsets from immunogenic variants of a murine mammary carcinoma: association with a differentially staining region on chromosome 9. Genes Chromosomes Cancer 3: 433-442.
19. Carlow DA, Kerbel RS, Feltis JT, Elliott BE 1985 Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma. J Natl Cancer Inst 75: 291-301. (Pubitemid 15229335)
20. Kong YM, Jacob JB, Flynn JC, Elliott BE, Wei W-Z 2009 Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy. Autoimmun Rev 9: 28-33.
21. Fuller BE, Giraldo AA, Waldmann H, Cobbold SP, Kong YM 1994 Depletion of CD4+ and CD8+ cells eliminates immunologic memory of thyroiditogenicity in murine experimental autoimmune thyroiditis. Autoimmunity 19: 161-168.
22. Lowenthal JW, Corthésy P, Tougne C, Lees R, MacDonald HR, Nabholz M 1985 High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with onoclonal anti-receptor antibody PC61. J Immunol 135: 3988-3994. (Pubitemid 16250380)
23. Kong YM 2007 Experimental autoimmune thyroiditis in the mouse. In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W (eds) Current Protocols in Immunology. John Wiley & Sons, Inc., New York, pp 15.7.1-15.7.21.
24. Nabozny GH, Kong YM 1992 Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1b. J Immunol 149: 1086-1092.
25. Kong YM, Morris GP, Brown NK, Yan Y, Flynn JC, David CS 2009 Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmun 33: 239-246.
26. Morris GP, Kong YM 2006 Tolerance to autoimmune thyroiditis: CD4+CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction. Front Biosci 11: 1234-1243. (Pubitemid 43253415)